Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

HCW Biologics Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1/A
Revenues  0.04.15,390.8
            Revenue growth  -100.0%-99.9% 
Cost of goods sold  0.00.07,365.3
Gross profit  0.04.1-1,974.5
            Gross margin   100.0%-36.6%
Selling, general and administrative   [+]13.49.91,974.5
Other operating expenses  0.50.03,416.2
EBITDA   [+]-13.3-5.3-6,943.5
            EBITDA margin   -128.6%-128.8%
Depreciation and amortization  0.50.6421.8
EBIT   [+]-13.9-5.8-7,365.3
            EBIT margin   -142.6%-136.6%
Interest income  0.50.0 
Other income (expense), net  0.50.072.4
Pre-tax income  -12.9-5.8-7,292.9
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -12.9-5.8-7,292.9
            Net margin   -141.5%-135.3%
   
Basic EPS   [+]($0.69)($1.22)($1.70)
Diluted EPS   [+]($0.69)($1.22)($1.70)
   
Shares outstanding (basic)   [+]18.84.74,286.5
Shares outstanding (diluted)   [+]18.84.74,286.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy